# Xregen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xregen

- Industry: Biotechnology
- Headquarters: Hangzhou, China
- Total disclosed funding: $4.8M
- Latest round: Angel (Feb 24, 2022)
- Investors on record: 3

## About

Established in 2022 and based in Hangzhou, China, Xregen is a developer of height-enhancing technology for children, focusing on human genetic diagnosis and therapeutic technology development. As of 2023, it has more than 20 employees. Their product, Angaosu, has been launched in November 2022. The chief scientist, Academician Wen, specializes in regenerating the organism by adjusting the cellular microenvironment.

The company focuses on developing height enhancement solutions for children, and also includes human genetic diagnosis and treatment technology development, bio-based material polymerization technology development, medical research, and trial development. Currently, IKids-Growth, the company's exclusive IGF-1 (growth promoting factor) height enhancement solution, has passed real-world studies.

## Funding rounds

- Angel, Feb 24, 2022, $4.8M — K2VC, Oufang Angel, Wangdao Venture Capital

## Investors

- K2VC (https://capitalatlas.ai/funds/k2vc) — Angel
- Oufang Angel — Angel
- Wangdao Venture Capital (https://capitalatlas.ai/funds/wangdao-venture-capital) — Angel